The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Redx confirms Jounce deal lapses, Tirupati seals deal

Mon, 03rd Apr 2023 18:05

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company - Confirms that proposed all-share merger with Jounce Therapeutics has formally lapsed. Follows decision by Jounce to agree an alternative merger proposal with Concentra Biosciences, announced on March 27. Chief Executive Lisa Anson calls decision "disappointing," but notes Redx is "poised to achieve significant value inflection points from both clinical stage assets and development candidates in the next 12 months." Continues to evaluate relevant strategic and financial opportunities.

----------

Great Eastern Energy Corp Ltd - Asansol, India-based coal bed methane company - Confirms the last day of trading of the global depository receipts will be April 21. Following cancellation, GDRs will become unlisted GDRs. Apart from being unlisted, GDRs will continue to have the same structure as present.

----------

Litigation Capital Management Ltd - asset manager specialising in dispute financing solutions - Announces the realisation and cash receipt of an investment which forms part of LCM's Fund I portfolio. In December, High Court judged in favour LCM's funded party, the liquidator of CGL Realisations Ltd, formerly known as Comet Group Ltd. Under the judgement around GBP110 million was paid into court by the respondent who is appealing the ruling. In the interim, the liquidator procured a judgment protection insurance policy. Subsequently, an application was made for payment of sufficient monies to pay LCM's entitlements under the litigation funding agreement as well as the cost of defending the appeal. This enabled the liquidator to finalise its obligations to LCM, bringing about a conclusion to this investment. CEO Patrick Moloney says: "The resolution provides a further example of how the use of managed third party investment funds leverages the return to LCM's balance sheet and its equity investors."

----------

Kefi Gold and Copper PLC - Gold exploration and development company, focused on Ethiopia and Saudi Arabia - Reports maiden mineral resource estimate at the Al Godeyer Project, which forms part of the Hawiah Complex, part of Kefi's Saudi Arabian joint-venture Gold and Minerals Company Ltd. Says MRE of 1.4 million tonnes at 0.6% copper, 0.54% zinc, 1.4 grams per tonne of gold and 6.6 grams per tonne of silver potentially complements the inferred resources reported at the nearby Hawiah deposit of 11.1 million tonnes. This reaffirms the potential for an initial open-pit mining operation at Hawiah. Drilling planned to commence in the second quarter aimed at converting unclassified areas of the deposit to the Inferred category and to further test the strike extent of the orebody. Concurrent drilling planned at Hawiah will focus on upgrading and further expanding its total resources. Executive Chairman Harry Anagnostaras-Adams says: "Feedback from the early metallurgical test work is particularly exciting and demonstrates the amenability of Al Godeyer to provide additional open pit feed material to the proposed Hawiah Complex."

----------

Great Southern Copper PLC - copper-gold exploration company focused on Chile - Reports mapping identifies multiple mineralised vein-breccia structures at the Victoria prospect. Notes rock chip assay grades up to 6.9% copper and 1.85 grams per tonne of gold in the prospect. Sees potential for additional vein-breccia structures under shallow cover. Adds planning is now underway for the next phase of exploration at Victoria which is designed to identify targets for prospect-scale reconnaissance drilling. This work will include further detailed mapping and sampling complimented with trenching and magnetic and induced polarization geophysical surveys.

----------

San Leon Energy PLC - oil and gas production, development and exploration company focused on Nigeria - Updates on proposed transactions, refinancing and ELI operations. Reports longstop dates relation to proposed transactions with Midwestern Oil & Gas Co Ltd have been extended to June 30. This relates to the new Eroton debt facilities, the Sahara OML 18 acquisition agreement, the MLPL reorganisation agreement and the ELI reorganisation agreement. Continues to believe that the proposed transactions will be transformational.

----------

Tirupati Graphite PLC - London and Mumbai-based specialist graphite and graphene producer with operations in Madagascar and India - Completes acquisition of Suni Resources SA, the Mozambique incorporated subsidiary of ASX listed Battery Minerals Ltd. Deal was announced in September 2022.

----------

Provexis PLC - Reading, England-based producer of heart-health functional food ingredient Fruitflow - Updates on its capital structure and funding. Expects the group will need to raise further equity finance, or potentially new loan finance, in the coming months. Based on success of previous fund raising and the current performance of the business, continues to have a reasonable expectation of raising sufficient additional equity capital or new loan finance. Highlights renewed interest for Fruitflow. Committed to buy more than GBP550,000 of inventory from DSM. In direct contact with more than 50 actual and prospective Fruitflow customers and is seeking to ascertain the likely demand for the next 12 months and beyond, with particular regard to the best before dates of DSM's remaining inventory. In talks with DSM regarding extending initial inventory handover period. In talks with third party who may be able to hold inventory on a consignment basis.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
10 Jul 2019 10:40

WINNERS & LOSERS SUMMARY: PageGroup Slumps After Profit Warning

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - LOSERS----------Micro Focus down

Read more
10 Jul 2019 09:41

Redx Pharma Shares Double After Jazz Pharmaceutical Deal

(Alliance News) - Redx Pharma PLC said Wednesday it has signed a definitive agreement with Nasdaq-listed Jazz Pharmaceuticals PLC to sell its pan-RAF inhibitor programme.Shares in the and a

Read more
10 Jun 2019 10:10

Redx Pharma Gets GBP2.5 Million Financing As Interim Loss Narrows

LONDON (Alliance News) - Redx Pharma PLC on Monday said its loss narrowed in the first half of its current financial year as it progresses on cancer and idiopathic pulmonary fibrosis drugs the and

Read more
10 Jun 2019 08:29

Redx Pharma narrows losses as RXC004 trials recommence

(Sharecast News) - Drug discovery and development company Redx Pharma published its interim results on Monday, revealing it had narrowed first-half losses as it progresses on cancer and idiopathic pulmonary fibrosis drugs development.

Read more
3 May 2019 14:07

Redx Pharma Exploring New Financing Options Despite Progress

LONDON (Alliance News) - Cancer and fibrosis-focused drug firm Redx Pharma PLC is "greatly encouraged" by talks over securing new financing.In November, Redx said it was looking a

Read more
3 May 2019 11:17

Redx Pharma extends cash runway into July

(Sharecast News) - Drug discovery and development company Redx Pharma updated the market on its ongoing plans to strengthen its balance sheet on Friday, with its board reiterating its commitment to strengthening the balance sheet in order to extend the cash runway beyond the second quarter of 2019, as it initially announced in November.

Read more
12 Feb 2019 13:42

Redx Pharma reveals promising data on 'ROCK2' compound

(Sharecast News) - Drug discovery and development company Redx Pharma announced promising preclinical efficacy data for its lead selective 'ROCK2' compound on Tuesday.

Read more
12 Feb 2019 09:45

Redx Pharma Sees Promising Results From Liver Disease Treatment

LONDON (Alliance News) - Redx Pharma PLC said Tuesday that preclinical efficacy data for its ROCK2 compound showed the product was able to have an impact on established fibrosis.Shares in a

Read more
6 Feb 2019 11:45

Redx Pharma Receives Oustanding Loan Amounts From Redag

LONDON (Alliance News) - Redx Pharma PLC on Wednesday said that it received a full cash repayment of GBP869,126, representing the outstanding amount of a loan made in 2014 to Redag Crop Protection

Read more
31 Jan 2019 11:03

Deinove Backs Out Of Anti-Infective NBTI Programme With Redx Pharma

LONDON (Alliance News) - Redx Pharma PLC on Thursday said French biotech firm Deinove SA will not exercise its option for Redx's novel bacterial topoisomerase inhibitor programme.Shares

Read more
31 Jan 2019 09:45

Deinove hands rights to NBTI programme back to Redx Pharma

(Sharecast News) - Drug discovery and development company Redx Pharma announced on Thursday that Deinove had decided not to exercise its option for Redx's 'Novel Bacterial Topoisomerase Inhibitor' (NBTI) programme.

Read more
30 Nov 2018 10:36

Redx Pharma Drug Candidate RXC006 To Be Developed As Fibrosis Drug

LONDON (Alliance News) - Drug developer Redx Pharma PLC said Friday its RXC006 drug candidate was able to suppress lung fibrosis in living organisms and will be developed as a treatment for in up

Read more
30 Nov 2018 10:31

Redx Pharma jumps as first data shows 'great potential' for fibrosis candidate

(Sharecast News) - Redx Pharma made gains on Friday after it said that pre-clinical data suggested that its RXC006 drug candidate has "great potential" as a treatment for fibrosis.

Read more
19 Nov 2018 13:07

Redx Pharma Posts Large Annual Loss, Appoints Astra Executive As CFO

LONDON (Alliance News) - Redx Pharma PLC on Monday posted a large loss due to the absence of a big exceptional disposal gain seen a year before and said that it has appointed James Mead as its new

Read more
19 Nov 2018 08:59

Redx Pharma swings to a loss following 'seminal' year

(Sharecast News) - A year after clambering out of administration, drug discovery and development outfit Redx Pharma swung to a loss but remains confident of making progress with a drug pipeline refocused on cancer and fibrosis.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.